BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 30910137)

  • 1. Natural-cycle in vitro fertilization (IVF) combined with in vitro maturation in infertile patients with polycystic ovarian syndrome (PCOS) requiring IVF.
    González-Ortega C; Piña-Aguilar RE; Cancino-Villarreal P; Pérez-Peña E; Gutiérrez-Gutiérrez AM
    Taiwan J Obstet Gynecol; 2019 Mar; 58(2):192-195. PubMed ID: 30910137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparision of in vitro maturation applied in PCOS and non-PCOS patients undergo stimulated and unstimulated protocols].
    Wang P; Zhao J; Jin C; Yu R; Lin J; Zhu R; Wu Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):903-8. PubMed ID: 25608990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
    Siristatidis CS; Vrachnis N; Creatsa M; Maheshwari A; Bhattacharya S
    Cochrane Database Syst Rev; 2013 Oct; (10):CD006606. PubMed ID: 24101529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IVF versus ICSI for the fertilization of in-vitro matured human oocytes.
    Walls M; Junk S; Ryan JP; Hart R
    Reprod Biomed Online; 2012 Dec; 25(6):603-7. PubMed ID: 23063820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study.
    D'Amato G; Caringella AM; Stanziano A; Cantatore C; Palini S; Caroppo E
    Reprod Biol Endocrinol; 2018 Sep; 16(1):89. PubMed ID: 30217209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles.
    Gremeau AS; Andreadis N; Fatum M; Craig J; Turner K; McVeigh E; Child T
    Fertil Steril; 2012 Aug; 98(2):355-60. PubMed ID: 22658347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between mild stimulated IVF/M cycle and early embryo arrest in sub fertile women with/without PCOS.
    Elshewy N; Ji D; Zhang Z; Chen D; Chen B; Xue R; Wu H; Wang J; Zhou P; Cao Y
    Reprod Biol Endocrinol; 2020 Jul; 18(1):71. PubMed ID: 32669130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
    Li X; Ding W; Liu JY; Mao YD; Huang J; Wang W; Ma X
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):402-408. PubMed ID: 29961283
    [No Abstract]   [Full Text] [Related]  

  • 13. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.
    Heijnen EM; Eijkemans MJ; Hughes EG; Laven JS; Macklon NS; Fauser BC
    Hum Reprod Update; 2006; 12(1):13-21. PubMed ID: 16123051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of assistant treatment proposals for infertile women with polycystic ovary syndrome].
    Chen ZJ; Shi YH; Li Y; Gao Q; Sheng Y; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):571-5. PubMed ID: 19087489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical application of in vitro maturation of human immature oocytes for infertile women with polycystic ovary syndrome].
    Xu YP; Xiang HF; Zou WW; Li ZL; Zhang ZG; Zhou P; Cao YX
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):14-8. PubMed ID: 22455687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility.
    Okohue JE; Onuh SO; Ikimalo JI
    Niger J Clin Pract; 2013; 16(2):207-10. PubMed ID: 23563463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blastocyst development and pregnancies after IVF of mature oocytes retrieved from unstimulated patients with PCOS after in-vivo HCG priming.
    Son WY; Yoon SH; Lee SW; Ko Y; Yoon HG; Lim JH
    Hum Reprod; 2002 Jan; 17(1):134-6. PubMed ID: 11756376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.